Research
HIV / STI
The World Health Organization’s global health sector strategies on HIV and sexually transmitted infections (STI) aim to achieving the goals of ending AIDS by 2030.
Our Research Team has adopted an interdisciplinary approach to conduct HIV/STI studies for informing the development of effective public health interventions. Our studies have enhanced the understanding of the distribution and determinants of the diseases in Hong Kong, in the contexts of time, place and person. Studies on STI includes gonorrhoea, chlamydia, syphilis, Mycoplasma genitalium infection, and mpox.
Clinical research
- Co-morbidities in people living with HIV (PLWH)
- Immune recovery following antiretroviral therapy
- Pre-exposure prophylaxis (PrEP) prospective clinical trials in men who have sex with men (MSM)
- Clinical trial on the use of a Meningococcal B vaccine for gonorrhoea prevention
- Clinical trials on differential delivery models for HIV self-test
- HIV drug resistance profile
Laboratory research
- Therapeutic drug monitoring on commonly used antiretroviral drugs for HIV
- Antimicrobial resistant Mycoplasma genitalium
- Metagenomic analysis of the serum microbiome of PLWH
- Phylodynamics and transmission network of HIV among different populations
Public health research
- PrEP implementation study
- Relationship between chemsex engagement and HIV biomedical prevention
- Evaluation of blood donor deferral policy
- Mathematical modelling of HIV/STI and cost-effectiveness analysis on interventions
- Self-sampled multi-anatomic site testing for STI
- Mpox vaccination coverage
- Spatial epidemiology of syphilis
- Community perception on functional cure for HIV
- Effect of social network on HIV prevention and transmission
- mHealth approach for HIV prevention and care
- Travel and sexual health
- Methadone clinic utilisation and health outcomes using data mining